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Neutrophils are part of a family of granulocytes that, together with eosinophils and
basophils, play an essential role in innate immunity. Neutrophils are the most abundant
circulating leukocytes and are vital for rapid immune responses, being recruited to sites
of injury or infection within minutes, where they can act as specialized phagocytic cells.
However, another prominent function of neutrophils is the release of pro-inflammatory
compounds, including cytokines, chemokines, and digestive enzymes, which are stored in
intracellular compartments and released through regulated exocytosis. Hence, an impor-
tant feature that contributes to rapid immune responses is capacity of neutrophils to
synthesize and store pre-formed pro-inflammatory mediators in specialized intracellular
vesicles and thus no new synthesis is required. This review will focus on advancement in
three topics relevant to neutrophil secretion. First, we will examine what is known about
basal level pro-inflammatory mediator synthesis, trafficking, and storage in secretory com-
partments. Second, we will review recent advancements in the mechanisms that control
vesicle mobilization and the release of pre-formed mediators. Third, we will examine the
upregulation and de novo synthesis of pro-inflammatory mediators by neutrophils engaged
at sites of infection.
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INTRODUCTION
Neutrophils are the most abundant leukocytes in blood, com-
prising 60–70% of all circulating white blood cells, and there-
fore, make up an essential part of both innate and adaptive
immunity. Neutrophils are highly mobile and provide rapid
responses to infection via phagocytosis of pathogens or release
of potent pro-inflammatory mediators that chemically incapaci-
tate pathogens and infected cells. Neutrophils are also recruited to
the site of injury following trauma, resulting in an acute inflam-
matory response. Their short-life span allows for quick resolu-
tion of inflammation and can promote wound healing through
stimulation of local tissue remodeling and chemoattraction of
macrophage (1). Neutrophil immunity function depends on both
the biogenesis of granules that store proteins with active antimi-
crobial activity, and on their ability to generate oxidative burst.
Defects in either of these two processes results in severe immun-
odeficiency such as neutropenia, neutrophil-specific granule defi-
ciencies, or chronic granulomatous disease when oxidative burst is
lacking (2). In this review, we will consider the protein processing
events that occur in neutrophils, resulting in their initial granu-
locytic morphology, and protein transitions that occur to activate
neutrophil “attack” mode.
GRANULOCYTOPOIESIS
NEUTROPHIL DIFFERENTIATION FROM BONE MARROW
Mature neutrophils are differentiated from hematopoietic stem
cells in the bone marrow in a process termed granulocytopoiesis
or granulopoiesis (3). New neutrophils are produced daily in high
numbers, up to 1011 in healthy individuals, which can increase
several fold during infection (4). Consequently, neutrophil home-
ostasis is highly regulated to control their numbers. Granulocyte-
colony-stimulating factor (G-CSF) is the principal cytokine reg-
ulating granulocytopoiesis. Lack of G-CSF production impairs
granulocytopoiesis, resulting in neutropenia and severe immune
deficiency (5, 6). Hematopoietic stem cell differentiation into
granulocytes is regulated by the coordinated expression of three
key myeloid transcription factors, GFI-1, PU.1, and members of
the CCAAT enhancer binding protein family (C/EBPs). The bal-
ance between PU.1 and C/EBPα determines whether myeloblasts
differentiate into granulocytes (high C/EBPα) or monocytes (high
PU.1) (7).
The chemokines CXCL12 and CXCL2 and their neutrophil
receptors, CXCR4 and CXCR2, respectively, regulate the release
of neutrophils from the bone marrow. CXCR4–CXCL12 signaling
promotes bone marrow retention, while CXCL2–CXCR2 pro-
motes their release in what has been described as a tug of war
model. The contribution of these chemokine signaling pathways
to the regulation of neutrophil trafficking from bone marrow has
been recently reviewed (8).
NEUTROPHIL DIFFERENTIATION FROM STEM CELLS
Neutrophils have been developed from human embryonic stem
cells (hESCs) in culture. High yields were achieved by grow-
ing hESC in co-culture with semi-confluent OP9 stromal cells
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to stimulate hESC differentiation (9). The OP9 stromal cell line,
which is derived from the osteopetrotic mouse, was specifically
selected since they lack production of macrophage-colony stim-
ulating factor (M-CSF) and thus support neutrophil rather than
macrophage differentiation (10, 11). The procedure was further
improved using a unique cytokine cocktail to yield highly func-
tional neutrophils capable of chemotaxis, phagocytosis, oxidative
burst, and bacterial killing (12, 13). Recently, protocols have
been reported that differentiated neutrophils can be prepared
from induced pluripotent stem cells (iPSCs) (14–16). These are
significant advancements since the ability to obtain functional
neutrophils from hESCs, iPSCs, and even patient-derived iPSCs
may progress toward their eventual use in the treatment of
hematopoietic disorders (17, 18).
NEUTROPHIL GRANULARITY
SEQUENTIAL SYNTHESIS MODEL
Mature neutrophils emerge in the blood devoid of any prolifera-
tive capacity, but fully capable of launching an immune response.
Ultrastructural images of mature neutrophils reveal a character-
istic multi-lobed nucleus, very few mitochondria, a small Golgi
structure, and a highly granular cytosol that is packed with vesicles
(Figure 1A). The presence of different granule subsets is revealed
by their varying size and intensity of stained with the peroxidase-
reactive dye, 3,3′-diaminobenzidine (Figure 1B). Granule subsets
are also distinguished by their protein content and their propen-
sity for mobilization, which will be further discussed in following
sections (19–21).
The difference in protein contents among neutrophil granule
subsets is not driven by protein sorting. Instead, different granules
are sequentially formed during neutrophil differentiation in what
has been described as a targeting by timing model (23). According
to this model, as different granule proteins are synthesized dur-
ing different stages of neutrophil differentiation several granule
subsets are generated (24–26). Neutrophils have at least three dis-
tinct granule subsets: (i) primary or azurophilic granules, which
contain potent hydrolytic enzymes (e.g., elastase) and myeloper-
oxidases (MPO), (ii) secondary or specific granules, which contain
FIGURE 1 | Neutrophil morphology as observed by electron
microscopy. Neutrophils were isolated from human peripheral blood, and
processed for electron microscopy after incubation for 15 min at 37°C with
vehicle (A,B) or 10µM cytochalasin B and 5µM fMLF (C,D) as described
in Ref. (22). (A,B)The cytosol of a resting cell is filled with vesicles, with
primary granules (P) staining intensely dark with DAB, while secondary (S)
and tertiary (T) granules show more translucent staining. Secretory
vesicles (SV) are in close proximity to the Golgi complex (G). Few
mitochondria (M) are observed. (C,D) After stimulation only a few dense
primary granules (P) remain and many empty vesicles (EV) appear. A
double membrane autophagosome (AP) was observed to form around a
primary granule; however, the relevance of this observation is unknown.
Scale (A,C)=8µm×8µm, 9,100× magnification;
(B,D)=2.4µm×2.4µm, 27,600× magnification.
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high levels of the iron-binding protein lactoferrin, and (iii) tertiary
or gelatinase granules, which contain matrix metalloproteinases
(Figure 1B). Secondary and tertiary granules contain an overlap-
ping set of proteins; however, all granules have distinctive buoyant
densities and can be isolated by density gradient centrifugation
(27). Recently, a fourth granule population has been described
that was enriched in the microbial lectin ficolin-1. Ficolin-1 is
found in tertiary granules; however, the authors found a second
pool of ficolin-1-rich/gelatinase-poor granules with an elevated
exocytosis propensity (21, 28). The importance of these granules
may be to provide rapid release of pattern recognition molecules
to activate the lectin complement pathway (28). Secretory vesicles
(SV) also appear in density gradients that contain albumin indica-
tive of their formation via endocytosis. SV can also be formed in
mature neutrophils from a small Golgi structure (Figures 2A,B).
These contain cytokines synthesized during immune activation
indicative of an active biosynthetic pathway (29, 30), which will
be discussed further in Section “Neutrophil De Novo Synthesis of
Pro-Inflammatory Mediators.”
GRANULE PROTEIN SORTING
Neutrophil granule proteins undergo a series of co- and post-
translational processing and targeting events during sorting to
their granule sub-compartment. Most, if not all, proteins pack-
aged into neutrophil granules enter through the biosynthetic
process as deduced by the presence of amino-terminal signal
sequences for co-translational translocation into the endoplasmic
reticulum (ER). The emergence of this “pre” sequence from the
ribosome associates with the signal recognition particle, which
drives co-translation into the lumen of the ER, followed by post-
translational processing as proteins traverse the Golgi complex
(e.g., protein maturation via glycosylation).
The precise mechanism by which proteins are targeted to
neutrophil granules from the trans-Golgi network (TGN) is
largely unknown, hampered by the fact that these cells are end-
differentiated and do not synthesize granule proteins de novo.
However, much information has been gained from analogous
studies in other immune cells and the characterization of neu-
trophils from immunological disorders associated with sorting
defects (31, 32). These studies confirm that neutrophils gener-
ate lysosome-like secretory granules both directly from the TGN
and indirectly via a sorting endosomes (Figure 3). Post-TGN sort-
ing is mediated by the multi-subunit adaptor protein complexes
(APs) and the monomeric Golgi-localized γ-adaptin ear homol-
ogy ARF binding (GGAs) protein. Both nucleate clathrin-coated
vesicles and recruit luminal cargo for packaging into the vesicles
(33). Three of the five known AP complexes function at the TGN
and are likely involved in granule sorting since they have promi-
nent roles in lysosomal sorting in other cell types (33, 34). AP-1
and GGAs direct the bulk sorting program from the TGN to sort-
ing endosomes, while AP-3 and AP-4 shuttle cargo to granules
from the sorting endosomes or directly from the TGN, bypassing
the sorting endosomes (35). This distinction in pathways serves
an important mechanistic role since soluble cargo utilizes recep-
tors that require a dissociation step catalyzed in endosomes. This
allows the receptor to be sorted back to the TGN while the cargo
is transported into granules (Figure 3).
The sorting of granule membrane proteins, including cargo
receptors, depends on dileucine or tyrosine-based sorting signals
present in carboxy-terminal cytosolic domains (35). The consen-
sus dileucine sequences, DXXLL or [DE]XXXL[LI], and tyrosine
sequence, [G]YXXØ (where X represents hydrophobic residues
and Ø a bulky hydrophobic amino acid), interact with GGAs/AP-1
and AP-3/AP-4 complexes, respectively.
The majority of soluble hydrolases and granzymes are modified
with mannose-6-phosphate (M6P) in the Golgi, which is recog-
nized by M6P-receptors to facilitate their exit from the TGN (33).
Unlike hydrolases and granzymes, many soluble granule proteases
are sorted via M6P-independent mechanisms (31, 36). Targeting
of the major serine protease, neutrophil elastase, as well as other
proteases requires AP-3 (37). Neutrophil elastase contains a tyro-
sine on the cytosolic face of it trans-membrane pro-domain, which
interacts with AP-3 presumably for its sorting (38). However, neu-
trophil elastase mutants that lack a pro-domain still get sorted to
FIGURE 2 | Neutrophil Golgi complex as observed by electron
microscopy. Neutrophils processed for electron microscopy as described in
Ref. (22) show a small stacked Golgi with an increase in electron dense
vesicle (arrows) after stimulation. Conditions were incubation with vehicle (A)
or 10µM cytochalasin B and 5µM fMLF (B) for 15 min at 37°C. Scale,
2.4µm×2.4µm, 27,600× magnification.
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FIGURE 3 | Schematic of neutrophil protein sorting pathways. Three
prominent trafficking pathways for granule proteins are depicted:
AP-1/GGA-dileucine based sorting, AP-3/AP-4-tyrosine-based sorting, and
selective clustering-based sorting. Soluble hydrolases contain M6P signals
and are sorted via the M6P-receptors, which contain dileucine signals. These
complexes are shuttle to the sorting endosome through GGA and
AP-1-dependent pathways. In the endosome, a drop in pH results in
dissociation of the receptor–cargo complex with the retrieval of the
M6P-receptor by an AP-1 dependent pathway. Serine proteases (neutrophil
elastase, proNE) and trans-membrane proteins (CD63) contain tyrosine
signals and are sorted directly to granules via AP-3/AP-4. Many granule
proteins contain neither dileucine nor tyrosine signals and are thought to sort
to granules via a clustering-based pathway since this occurs for many granule
proteins that are highly concentrated. CD63 trafficking is unique as it can be
found on several neutrophil membranes and may act to selectively retrieve
granule proteins that escape normal trafficking via constitutive secretion.
granules via a CD63-dependent mechanism (39). CD63, an abun-
dant membrane protein of primary granules, is sorted by AP-3, and
has been shown to play a role in granule protein quality control
since it can be trafficked from many membranes to granules (40,
41). A recent study showed that CD63 and neutrophil elastase are
present in a complex, highly indicative of a role for CD63 in the tar-
geting of elastase to primary granules (42). Other serine proteases
affected by CD63 granule sorting include proteinase-3 (39), and
possibly the cathepsin family of proteases, which exhibit varying
degrees of M6P-dependent/independent sorting (36, 43–45).
Neutrophils, as well as other granulocytes, may have acquired
additional unique granule sorting mechanisms based on the fact
that proteins in some granules can be tightly packed to the point of
having a crystalline core. A selective aggregation of proteins des-
tined for storage in granules would eliminate the need for distinct
sorting motifs on each granule protein (24). Granule proteins,
which are often cationic, may be clustered with serglycin, a major
anionic proteoglycan of hematopoietic cells. Serglycin has been
proposed to play a role in sorting and packing of several granule
proteins including α-defensin and elastase (46, 47). Neutrophil
elastase is absent from mature neutrophils in serglycin knock-out
mice (48). Whether serglycin-induced clustering of granule pro-
teins promotes granule localization via sorting or their retention
in granules is still under investigation (49).
Most granule enzymes are synthesized as zymogens and
undergo a proteolytic processing step that depends on the acidic
pH levels within this lysosome-like compartment. The proteolytic
cleavage of granule pro-domains converts these enzymes into their
active forms and thus many granule proteins are maintained inac-
tive until the proper compartment is reached. Some pro-domains
have also been shown to have a role in sorting. The amino-terminal
pro-peptide of pro-MPO has been shown to facilitate its targeting
to primary granules (50). Unlike MPO, serine proteases (e.g., elas-
tase and cathepsin G) are synthesized with both amino-terminal
and carboxy-terminal pro-peptides that do not seem to be involved
in their sorting (51).
IMMUNE DISORDERS FROM GRANULE PROTEIN SORTING DEFECTS
Granule protein trafficking disorders often manifest as lysosomal
storage disorders (LSDs), which are a large group of metabolic dis-
eases that result from deficiencies in specific lysosomal enzymes
or defects in lysosome biogenesis (31, 52). For instance, defects
in the ability to generate M6P sorting signals in the Golgi result
in the LSDs mucolipidosis II (also referred to as I-cell disease)
and mucolipidosis III. Mutations in GlcNAc-phosphotransferase
are believed to be the primary genetic defect in mucolipidosis.
GlcNAc-phosphotransferase activity is absent in MLII and altered
in MLIII (53). Studies of patients with mucolipidosis revealed
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neutropenia, with a major reduction in the number of neutrophils
in MLII, but less severe in MLIII patients (53, 54). There have been
no reports of neutrophil function studies from these patients, but
presumably granules would lack most soluble hydrolases since
these are sorted by the M6P pathway. However, studies of B
lymphocytes showed that a portion of lysosomal enzymes were
retained in granules with an unknown a back-up sorting event
facilitating this partial sorting (36). The recent development of
a mucolipidosis II mouse model might advance neutrophil func-
tional characterizations (55, 56). These studies could reveal the
prominence of M6P-independent sorting pathways in neutrophils
and whether these can facilitate the partial retention of enzymes
normally sorted by M6P.
Hermansky–Pudlak syndrome type 2 is also a LSD disorder
that results from a mutation in AP3B1, which encodes a subunit
of the AP-3 complex. The type 2 form includes immunodeficiency
associated with neutropenia and partial albinism. The basis of this
disease was first discovered as a similar autosomal recessive dis-
ease of dogs, canine cyclic hematopoiesis (38). The lack of AP-3
sorting resulted in reduced levels of neutrophil elastase and gelati-
nase in granules, but normal levels of other enzymes such as MPO
and proteinase-3, which reside in the same granule fraction as
elastase (57). This reveals the divergence in sorting pathways in
neutrophils; AP-3 for neutrophil elastase versus GGA/AP-1 for
MPO. Interestingly, AP-3 deficiency leads to congenital neutrope-
nia in humans and cyclic neutropenia in dogs (38, 58), even though
both are linked to the lack of neutrophil elastase sorting. Neu-
trophil elastase mutations cause a much more severe congenital
neutropenia phenotype in humans (59). It has been suggested
that increased apoptosis of myeloid precursors in patients carry-
ing mutations in the elastase gene could lead to a maturation arrest
of myelopoiesis and this triggers the more severe neutropenia
phenotype (60).
Although neutrophil elastase is a soluble protein, there is evi-
dence that in an intermediate stage of its processing it is a disulfide
bonded trans-membrane protein (38). Upon enzymatic removal
of the carboxy-terminal pro-domain, the protein maintains a
trans-membrane conformation capable of associating with AP-
3 complexes. Membrane-associated neutrophil elastase utilizes
a tyrosine-based sorting signal that is located in the carboxy-
terminal domain of the protein. Most elastase mutations asso-
ciated with severe congenital neutropenia result in the removal
of this sorting signal (38). Horwitz et al. have proposed that
the localization of the enzyme in the lumen of granules or on
the plasma membrane may regulate the differentiation pattern
of myeloid progenitor cells into monocytes or granulocytes. This
suggests that neutropenia may result from a defective differenti-
ation switch between the monocytic and granulocytic lineage of
myelopoiesis (61, 62). This is an appealing hypothesis that may
account for the observation that granulocytes and monocytes rec-
iprocally cycle in numbers during normal hematopoiesis and for
the typical increase of monocyte blood counts observed in the
majority of severe congenital neutropenia patients. Hence, not
only granule sorting pathways are important for granule biogen-
esis but also in determining the population of cell types during
hematopoiesis.
PROTEIN PROCESSING IN ACTIVATED NEUTROPHILS
Three functions that involve protein processing occur in neu-
trophils when activated for an immune response: (1) neutrophil
migration up chemotactic gradients to sites of infection, (2)
destruction of pathogens or injured/infected cells through oxida-
tive burst and phagocytosis, and (3) mobilization of granules and
release of inflammatory mediators. In this section, we review these
functions with a particular focus on the mobilization of granules
and the release of pre-formed inflammatory mediators.
NEUTROPHIL CHEMOTAXIS
Upon activation, neutrophils migrate out of blood vessels follow-
ing gradients of chemoattractants in a process known as chemo-
taxis. Neutrophils respond to a wide range of “neutrophil-active”
chemoattractants, including chemokines and cytokines (CXCL8,
IFNγ), complement (C5a), eicosanoids (LTB4), and pathogen-
derived peptides such as formylated met–leu–phe (fMLF) (63,
64). Chemotaxis begins with neutrophil recruitment from circula-
tion through physical interactions of neutrophil-specific adhesion
molecules. The neutrophil adhesion cascade is the focus of recent
reviews and therefore only briefly described here (65, 66). Neu-
trophils are initially tethered by selectin interactions, which can
be upregulated on the surface of endothelial cells (E-selectin) and
leukocytes (L-selectin). The lectin-like domains of selectins inter-
act with sialylated carbohydrate groups present on surface pro-
teins. This results in the characteristic rolling of neutrophils along
the luminal side of the endothelium. Reduced velocity allows neu-
trophils to recognize chemokines on the surface of the endothe-
lium, which activates integrins. Neutrophils will be released from
low-affinity selectin interactions unless firm adhesive contacts are
made between integrins and endothelial intracellular adhesion
molecules (ICAMs). Integrin ligation triggers intracellular signal-
ing for cytoskeletal rearrangement, which polarizes neutrophils
and drives transmigration through the endothelium (diapedesis).
Integrin signaling is essential as deficiencies result in leukocyte
adhesion deficiency, which not only causes defects in chemotaxis
and adhesion but also in phagocytosis and respiratory burst (2).
Regulation of the adhesion and chemotaxis requires the coordi-
nation of multiple protein signaling and processing events, which
result in cytoskeletal rearrangements that generate cell polarity
(67). The activation of distinct Rho proteins at the front (Rac1)
and back (RhoA) of neutrophils create actin formations that drive
movement (68). Rho proteins are central regulators of multiple
intracellular processes, and it is interesting how signaling down-
stream from Rho has evolved to coordinate cytoskeletal remodel-
ing in conjunction with other processes required for immune cell
functions. These include many non-cytoskeletal-related functions
such as regulation of gene transcription (69–72), calcium flux (73,
74), and oxidative burst (75–77).
Chemokines interact with G protein-coupled receptors
(GPCRs) on the surface of neutrophils. One pathway activated by
GPCRs is the lipid kinase pathway. PI3-kinase is activated, which
converts phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] into
phosphatidylinositol-3,4,5-triphosphate [PI(3,4,5)P3] at the
plasma membrane. PI(3,4,5)P3 stimulates F-actin reorganization
at the leading edge driving lamellipodia formation. The Rac
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GEFs, Vav1, and P-Rex1, bind PI(3,4,5)P3 via pleckstrin homol-
ogy domains, activating Rac, which leads to the production of
branched actin filaments at the leading edge (78–80). High lev-
els of the phosphatase PTEN are present in the trailing edge
of neutrophils, which consumes PI(3,4,5)P3. Thus, a gradient of
PI(3,4,5)P3 is established toward the leading edge, which promotes
polarization and directional motility (81). A recent report exam-
ined neutrophils derived from a conditional PTEN knock-out and
showed it not only functions in polarization but also prioritizes
chemoattractant signals. Normal neutrophils were shown to pre-
fer bacterial chemoattractants over endogenous chemokines, but
this preferential selection was lost in the PTEN knock-out (82).
Opposing roles for the two Rho proteins, RhoA and Cdc42,
in the trailing edge (or uropod) were shown by examining neu-
trophils devoid of these proteins. In the absence of RhoA, neu-
trophil priming was unregulated, resulting in hyper-responsive
activation and uncoordinated motility (83). Cdc42, on the other
hand, was required specifically to maintain neutrophil polarity
(84). WASp, a downstream Cdc42 effector, regulated polarity
through the CD11b integrin, which recruits the microtubule end
binding protein, EB1, to capture and stabilize microtubules at
the uropod. This would allow the generation of “pushing” forces
from the back of neutrophils. Cross-talk between Rho proteins has
been an area of intense investigation (68) and these results show
how Rho/Cdc42 signaling cross-talking can coordinately control
neutrophil chemotaxis while at the same time minimize other
immunity functions such as degranulation.
PHAGOCYTOSIS AND RESPIRATORY BURST
Neutrophil phagocytosis has been the focus of several reviews (85–
87). For the purpose of this review, we will limit our consideration
to the protein processes involved in NADPH oxidase assembly and
how this is directed primarily to the phagosomal membrane.
The rapid immunological response of neutrophils not only
depends partly on pre-formed granule proteins with antimicro-
bial activity but also on the ability to generate respiratory burst
activity. Deficiency in respiratory burst results in a severe immun-
odeficiency called chronic granulomatous disease (2). Chronic
granulomatous disease is linked to genetic abnormalities in any
one of the five “phox” proteins, which comprise the NADPH
oxidase complex. The small GTPase Rac is a sixth component
that is physically part of the oxidase complex that regulates its
function (75).
The NADPH oxidase complex generates reactive oxygen species
(ROS) that are crucial for antimicrobial activity and antigen pro-
cessing. However, excessive ROS production causes tissue damage
and oxidative stress and therefore neutrophils must precisely con-
trol both the location and timing of NADPH oxidase activity. In
unstimulated neutrophils, three oxidase subunits, p47-phox, p67-
phox, and p40-phox, are cytosolic. Rac2 is also cytosolic, bound
to its natural inhibitor RhoGDI. The remaining two subunits,
gp91-phox and p22-phox, form the membrane-spanning catalytic
core of cytochrome b558. Formation of the holoenzyme allows
electrons to follow from NADPH bound at the cytosolic face of
the complex, to FAD-bound cytochrome b558, which has two
heme-bound oxygen groups that accept the electrons and produce
superoxide.
The oxidase complex can be preferentially incorporated into
the phagosome during pathogen endocytosis, which minimizes
collateral tissue damage. However, residual oxidase complex at the
plasma membrane or its activation in the absence of phagocyto-
sis results in the release of ROS extracellularly. Three regulatory
steps may facilitate the phagosomal-predominant spatial activa-
tion of the oxidase complex. p47-phox phosphorylation leads
to a conformational change that exposes two amino-terminal
SH3 domains, which interact with the proline-rich region of
the membrane-bound p22-phox (88). Assembly that occurs on
the plasma membrane is susceptible to in rapid dephosphoryla-
tion, resulting in unproductive oxidase assembly. Second is the
regulation of the p40-phox subunit by PI3-kinase. This effect
is mediated by the PX domain of p40-phox binding to PI(3)P,
which results in an open conformation allowing NADPH access
to the catalytic core (89, 90). PI(3)P is enriched on phagosome
membranes, which facilitates the spatial restriction of oxidase
activity to the phagosome rather than at the plasma mem-
brane where the predominant phosphoinositol lipids are PI(4,5)P2
and PI(3,4,5)P3. A third regulatory step involves Rac. Rac is
activated by guanine nucleotide exchange factors (GEFs) from
the Vav or P-Rex families (78–80, 91). The function of these
GEFs depend on membrane recruitment via increased levels of
PI(3,4,5)P3 (92). However, this create a spatial paradox since
PI(3,4,5)P3 is localized to the plasma membrane and not phago-
somes. This is resolved by the oxidase complex showing prefer-
ence for assembly with Rac2 over Rac1 (91, 93, 94). While Rac1
is predominantly localized to the plasma membrane, Rac2 has
less affinity for the plasma membrane, likely due to fewer poly-
basic residues in its carboxy-terminus (95). This may result in
spontaneous disassembly from the oxidase complex in the pres-
ence of high levels of PI(4,5)P2 and PI(3,4,5)P3, unless rapidly
endocytosis occurs and the highly acidic phosphoinositides are
metabolized.
Interestingly, the Rac GEF Vav has also been shown to affect oxi-
dase assembly through a secondary affect involving the p40-phox
subunit (96). This may involve other downstream effectors of Rac,
which includes the serine kinase PAK1, which has been shown to
phosphorylation p47-phox (97). In addition, RhoA has recently
been shown to downregulate ROS production (98). The RhoA
signaling pathway was linked to cytoskeletal remodeling, which
would provide for an elegant way to downregulate oxidase activity
during chemotaxis. Further studies of the convergence of multi-
ple signaling pathways will be needed to reveal the full control of
oxidase activity.
GRANULE MOBILIZATION AND REGULATION OF EXOCYTOSIS
Neutrophils, upon stimulation undergo a series of immediate
changes without the need for de novo synthesis of proteins (com-
pare Figures 1A and 1B vs. 1C and 1D). Exocytosis, also known
as degranulation in neutrophil, is the release pre-formed media-
tors from granules. Granule subsets are markedly different in their
capacity for mobilization in response to stimulation (99, 100).
Granules formed during the later stages of granulocytopoiesis are
more prone to undergo exocytosis than granules formed during
the earlier stages. A recent study reported exocytosis levels of 100%
for SV, 38% for tertiary granules, 22% for secondary granules, and
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only 7% for primary granules after stimulation (28). The specific
steps of exocytosis involve granule translocation toward a target
membrane via actin remodeling and microtubule assembly, fol-
lowed by tethering and docking through the sequential action of
the core fusion machinery of Rab and SNARE proteins (Figure 4)
(101, 102).
Neutrophil granule contents, which include MPO, elastase,
lactoferrin, and matrix metalloproteinases, possess potent antimi-
crobial activity but are also highly cytotoxic. Therefore, their
release is highly regulated by binary signals to minimize aber-
rant degranulation. The first of these binary signals is adhesion-
dependent while the second involves activation of immune recep-
tors by ligand interactions. The adhesion-dependent step in vivo
involves β2-integrins (100), which can be reconstituted in vitro by
adhesion to biological surfaces or the addition of actin depoly-
merizing agents (22, 103, 104). The adhesion-dependent signaling
cascade for degranulation operates through the Src kinases Fgr
and Hck. Neutrophils from double knock-out hck−/− fgr−/−,
while still able to adhere to substrate, fail to undergo degranu-
lation in response to tumor necrosis factor (TNF) (105). However,
Src kinases are well known to be membrane proximal regulators
of neutrophil degranulation during receptor-mediated activation,
which comprises the second half of the binary signal (106, 107).
For example, degranulation requires immune receptor–ligand
interactions such as formylated peptides binding to GPCRs. This
also triggers the activation of Src kinases, and hence it is curious
why binary signals are needed that seemingly activate the same
signaling cascade. Binary signals may be needed to reach an activa-
tion threshold for degranulation or perhaps distinct downstream
pathways are activated. One downstream pathway specifically acti-
vated by the receptor-mediated kinase cascade is Ca2+ release
from intracellular stores (107). Increasing concentrations of Ca2+
are responsible for the hierarchical release of neutrophil granules
in the order of secretory vesicles> tertiary granules> secondary
granules> primary granules (99).
Cross-talk between the binary degranulation signals makes it
difficult to clearly define each signaling pathways. For example,
recently a role for the highly abundant non-receptor tyrosine
kinase, proline-rich kinase 2 (Pyk2), was described for degranu-
lation (108). Pyk2 undergoes auto-phosphorylation after integrin
ligation in calcium-dependent manner, allowing its association
with the Src-family kinases. Furthermore, studies with pyk2−/−
cells have shown its effect is mediated through paxillin and Vav,
which are both phosphorylated by Pyk2 (108). Vav is a direct
FIGURE 4 | Schematic of neutrophil signaling pathways regulating
degranulation. Two pathways that regulate granule mobilization are depicted:
upstream kinase cascade and downstream fusion machinery. Activation of
neutrophils through surface receptors triggers the activation of a kinase
cascade. Central downstream effectors of these kinases target cytoskeletal
remodeling, these include Vav, which activates Rac, paxillin, which facilitates
microtubule polarization, and the generation of PI(3,4,5)P3, which facilitates
polarization and actin remodeling. Note that Rac is activated at multiple points
in the signaling pathways (Vav*, P-Rex*) and hence may be needed for
several immune cell functions in addition to degranulation. Granule tethering
is regulated by Rab27 recruitment of Munc13-4. Munc13-4 is a
calcium-sensitive link between Rab function and the fusion machinery of
SNAREs. The Munc13-4:SNARE interaction requires calcium flux and is
targeted by PKC, which are activated in the upstream kinase cascade.
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activator of Rac, which remodels actin to facilitate degranulation
(78), while paxillin serves as an important scaffolding protein and
has a direct effect on microtubule assembly, which may contribute
to polarized granule motility (109). Thus, Pyk2 signaling may
be central to the transduction of multiple upstream signals into
downstream granule mobilization and degranulation (Figure 4).
Downstream events are regulated by distinct core fusion
machinery that drives granule docking and exocytosis at spe-
cific target membranes. Initially, Rab proteins tether vesicles to
target membranes, then SNARE proteins catalyze fusion (102).
Neutrophil granules fuse with target membranes when v-SNARES
pair with their corresponding t-SNARES. VAMP-2 is predomi-
nantly localized to SV and tertiary granules, whereas VAMP-7 is
predominantly localized to primary granules (110, 111). It seems
that the membrane density of VAMP-2 provides a functional
role in mobilization, docking, and fusion to the plasma mem-
brane, while VAMP-7 redirects vesicles to fuse predominantly with
phagosomes (110, 112).
Numerous additional regulatory proteins interact with the core
fusion machinery of Rabs and SNAREs. Among these, the Munc
family of proteins is important regulators of SNARE complex
formation (101). Munc13-4 (also known as UNC13D) is highly
expressed in neutrophils and interacts with Rab27,which is the Rab
that direct granules to dock at the plasma membrane. Munc13-4
tethers granules to the plasma membrane for exocytosis via two
calcium-sensitive lipid bind C2 domains (Figure 4) (113). Neu-
trophil subfractionation revealed that high levels of Munc13-4
rapidly translocate from the cytosol to granules upon stimulation
with a secretagogue like fMLF (114). In this study, Munc13-
4 was shown to associate with secondary and tertiary granules
and down-regulation of Munc13-4 using small interfering RNA
decreased their exocytosis (114). Recently, STK24 and CCM-3,
two regulators of neutrophil exocytosis, were shown to interact
with Munc13-4 (115). Lack of either STK24 or CCM-3 inhibited
degranulation; however, they were shown to play opposing roles in
the regulation of Munc13-4. Whereas STK24 inhibited Munc13-
4 function by binding its C2B domain, CCM-3 counteracted
STK24-mediated C2B inhibition (115). The STK24/CCM-3 com-
plex seems provide an important additional control mechanism
to halt aberrant degranulation.
NEUTROPHIL DE NOVO SYNTHESIS OF
PRO-INFLAMMATORY MEDIATORS
Neutrophils are well characterized for their ability to synthe-
size and secrete over 70 different cytokines, chemokines, and
growth factors. Although several of these have been character-
ized at the mRNA level only, 11 of these show controversial data
for human neutrophils (116). The trafficking pathways that gov-
ern the synthesis, storage, and release of these factors are poorly
understood. Several studies using immunogold staining analysis of
transmission electron microscopy have revealed that neutrophils
store pre-formed cytokines in secretory granules. Transforming
growth factor-α (TGFα) is stored as a pre-formed mediator in
secretory granules that are peroxidase-negative, suggesting local-
ization to secondary or tertiary granules (117). Similarly, TNF-α
was found as a pre-formed mediator in cytoplasmic vesicles fol-
lowing immunogold staining (118). However, the characteristics
of these cytoplasmic vesicles were not further elucidated in this
study. Other studies investigating cytokine and chemokine expres-
sion in neutrophils have indicated that mature peripheral blood
neutrophils possess pre-formed IL-6, IL-12, and CXCL2 in their
SV or tertiary granules (119).
In neutrophils, CD63 and CD68 are abundant membrane-
bound proteins in primary and secondary granules, and both of
these possess the YXXΦ motif, which interacts with AP-3/AP-4
complexes. AP-3 traffics cargo from tubular endosomes (recycling
endosomes) to late endosomes, lysosomes, and related organelles,
while AP-4 traffics protein from the TGN to endosomes or directly
to lysosomes (33, 35). This indicates that CD63 and CD68 may be
engaged in trafficking to primary and secondary granules through
recycling endosomes and late endosomes. Conversely, cytokines
that are secreted by neutrophils, including IL-1α/β, IL-6, CXCL8,
IL-12, TNF, IFNγ, CXCL2, TGFβ, MIP-1α/β, and VEGF do not
possess adaptor motifs, suggesting that they do not directly bind
to adaptors in order to enter sorting pathways for their traffick-
ing. Based on the absence of adaptor motifs in cytokines, it is
likely that cytokine trafficking is mainly determined by adaptor
motifs present in membrane proteins such as CD63 and CD68,
which direct cytokine cargo to appropriate granular and vesicular
compartments in cells.
Lipopolysaccharide (LPS) is major TLR agonist that is shed
from the outer membranes of Gram-negative bacteria,which cause
a significant burden of disease by inducing respiratory infec-
tions, gastrointestinal disorders, sepsis, pneumonia, and many
other transmissible infections. LPS stimulation results in substan-
tial production of TNF, a potent pro-inflammatory cytokine with
cytotoxic and pyrogenic effects. Neutrophils stimulated by LPS
have the ability to release TNF, potentially through granule stores
(118, 120). However, the mechanisms used to secrete cytokines and
chemokines has not been thoroughly investigated in neutrophils
although it is evident that SNAREs and other trafficking machinery
are required for exocytosis of cytokine and chemokine-carrying
granules (110, 111, 121, 122).
CONCLUSION
Granule exocytosis and release of their cytotoxic contents at the
plasma membrane is most often an undesirable effect of inflamma-
tion. We have highlighted many of the protein processes involved
in pro-inflammatory mediator synthesis and granule biogenesis.
Neutrophils possess several mechanisms that promote fusion of
granules with phagosomes to minimize the effect of neutrophil-
induced co-lateral tissue damage. However, in many inflammatory
disorders, such as acute lung injury, ischemia/reperfusion injury,
severe asphyxic asthma, rheumatoid arthritis, and septic shock,
excessive neutrophil degranulation is a common feature. Insight
into neutrophil protein processes holds much promise in the
future treatment of these diseases.
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